Vipis Pharmaceutics OÜ

Active Registry code 12212291 OÜ Soodevahe küla Registered 2 Jan 2012
Compare

Vipis Pharmaceutics OÜ is a OÜ based in Soodevahe küla, registry code 12212291, status: active. Main activity: Manufacture of medicines and other pharmaceutical preparations. Its annual report for 2024 shows revenue of €0 and 0 employees.

Revenue
0 €
Employees
0
±0 vs 2023

2024 · annual report, e-Äriregister

Position in the industry Manufacture of basic pharmaceutical products and pharmaceutical preparations · EMTAK 21

  • Revenue · 2024 0 €
    industry median 25 284 € · companies in the industry: 24

Taxes and turnover

No tax data available. EMTA publishes data for those who paid state taxes, filed a VAT return or had employees in the quarter. New and small companies may be missing.

Financials by year

2016 – 2025
Revenue, € 2024: 0 € · industry median 25 284 € · above 5% of the industry
010 00020 00030 00040 00050 0002016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: 0 € Industry median: 28 809 €20192020 Company: 0 € Industry median: 25 207 €20202021 Company: 0 € Industry median: 11 877 €20212022 Company: 0 € Industry median: 4 897 €20222023 Company: 0 € Industry median: 3 851 €20232024 Company: 0 € Industry median: 25 284 €20242025 Company: — Industry median: 48 003 €2025010 00020 00030 00040 00050 0002018 Company: — Industry median: —2019 Company: 0 € Industry median: 28 809 €20192020 Company: 0 € Industry median: 25 207 €2021 Company: 0 € Industry median: 11 877 €20212022 Company: 0 € Industry median: 4 897 €2023 Company: 0 € Industry median: 3 851 €20232024 Company: 0 € Industry median: 25 284 €2025 Company: — Industry median: 48 003 €2025
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2024: 0 € · industry median 0 € · above 45% of the industry
01 0002 0003 0002016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: 0 € Industry median: 2 812 €20192020 Company: 0 € Industry median: 97 €20202021 Company: 0 € Industry median: 0 €20212022 Company: 0 € Industry median: 0 €20222023 Company: 0 € Industry median: 0 €20232024 Company: 0 € Industry median: 0 €20242025 Company: — Industry median: 676 €202501 0002 0003 0002018 Company: — Industry median: —2019 Company: 0 € Industry median: 2 812 €20192020 Company: 0 € Industry median: 97 €2021 Company: 0 € Industry median: 0 €20212022 Company: 0 € Industry median: 0 €2023 Company: 0 € Industry median: 0 €20232024 Company: 0 € Industry median: 0 €2025 Company: — Industry median: 676 €2025
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 2 500 € · +0.0% vs 2024
05001 0001 5002 0002 5002016 Company: —20162017 Company: —20172018 Company: —20182019 Company: 2 500 €20192020 Company: 2 500 €20202021 Company: 2 500 €20212022 Company: 2 500 €20222023 Company: 2 500 €20232024 Company: 2 500 €20242025 Company: 2 500 €202505001 0001 5002 0002 5002018 Company: —2019 Company: 2 500 €20192020 Company: 2 500 €2021 Company: 2 500 €20212022 Company: 2 500 €2023 Company: 2 500 €20232024 Company: 2 500 €2025 Company: 2 500 €2025
Equity, € 2025: 2 500 € · +0.0% vs 2024
05001 0001 5002 0002 5002016 Company: —20162017 Company: —20172018 Company: —20182019 Company: 2 500 €20192020 Company: 2 500 €20202021 Company: 2 500 €20212022 Company: 2 500 €20222023 Company: 2 500 €20232024 Company: 2 500 €20242025 Company: 2 500 €202505001 0001 5002 0002 5002018 Company: —2019 Company: 2 500 €20192020 Company: 2 500 €2021 Company: 2 500 €20212022 Company: 2 500 €2023 Company: 2 500 €20232024 Company: 2 500 €2025 Company: 2 500 €2025
Employees 2025: 0 · industry median 28 · above 2% of the industry
0102030402016 Company: 0 Industry median: —20162017 Company: 0 Industry median: —20172018 Company: 0 Industry median: —20182019 Company: 0 Industry median: 3420192020 Company: 0 Industry median: 32.520202021 Company: 0 Industry median: —20212022 Company: 0 Industry median: —20222023 Company: 0 Industry median: 2520232024 Company: 0 Industry median: 3220242025 Company: 0 Industry median: 2820250102030402018 Company: 0 Industry median: —2019 Company: 0 Industry median: 3420192020 Company: 0 Industry median: 32.52021 Company: 0 Industry median: —20212022 Company: 0 Industry median: —2023 Company: 0 Industry median: 2520232024 Company: 0 Industry median: 322025 Company: 0 Industry median: 282025
  • Company
  • Industry median

Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 — — 0 2 500 2 500 0
2024 0 0 0 2 500 2 500 0
2023 0 0 0 2 500 2 500 0
2022 0 0 0 2 500 2 500 0
2021 0 0 0 2 500 2 500 0
2020 0 0 0 2 500 2 500 0
2019 0 0 0 2 500 2 500 0
2018 — — — — — 0
2017 — — — — — 0
2016 — — — — — 0
2015 — — — — — 0
2014 — — — — — 0
2013 — — — — — 0
2012 — — — — — 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Equity ratio
100.0 %
Equity / assets
Debt ratio
0.0 %
Liabilities / assets

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 3 Aug 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 1 Jul 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 3 Apr 2024 Company’s own e-Äriregister
2022 1 Jan 2022 – 31 Dec 2022 25 Jul 2023 Company’s own e-Äriregister
2021 1 Jan 2021 – 31 Dec 2021 22 Mar 2022 Company’s own e-Äriregister
2020 1 Jan 2020 – 31 Dec 2020 6 Apr 2021 Company’s own e-Äriregister
2019 1 Jan 2019 – 31 Dec 2019 3 Dec 2020 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 21201Manufacture of medicines and other pharmaceutical preparations Main
Rulings
Number, date Title Deadline State Document
Ä 10163871 / 8
1 Sep 2023
Amendment entry In force
1 Sep 2023
PDF
Ä 10163871 / 7
17 Jan 2018
Amendment entry In force
17 Jan 2018
PDF
Ä 10163871 / 6
2 Dec 2017
Amendment entry In force
2 Dec 2017
PDF
Ä 10163871 / 5
24 May 2017
Amendment entry In force
24 May 2017
PDF
Ä 10163871 / 4
18 Apr 2017
Amendment entry In force
18 Apr 2017
PDF
Ä 10163871 / M4
29 Apr 2016
Ruling to eliminate deficiencies in the annual report 29 May 2016 In force
29 Apr 2016
PDF
Ä 10163871 / M3
23 Feb 2016
Warning of deletion from the register: annual report not filed 26 Aug 2016 Deficiencies eliminated
25 May 2016
PDF
Ä 10163871 / 3
12 Feb 2014
Amendment entry In force
12 Feb 2014
PDF
Ä 10163871 / M2
31 Jan 2014
Ruling to eliminate deficiencies 10 Feb 2014 In force
31 Jan 2014
PDF
Ä 10163871 / 2
17 Oct 2013
Amendment entry In force
17 Oct 2013
PDF
Ä 10163871 / M1
16 Oct 2013
Ruling to eliminate deficiencies 15 Nov 2013 Deficiencies eliminated
17 Oct 2013
PDF
Ä 10163871
2 Jan 2012
First entry In force
2 Jan 2012
PDF

Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data